IE53520B1 - N-(4,5-dihydrothiazol-2-yl)-3-quinoline carboxamide derivatives - Google Patents

N-(4,5-dihydrothiazol-2-yl)-3-quinoline carboxamide derivatives

Info

Publication number
IE53520B1
IE53520B1 IE1394/82A IE139482A IE53520B1 IE 53520 B1 IE53520 B1 IE 53520B1 IE 1394/82 A IE1394/82 A IE 1394/82A IE 139482 A IE139482 A IE 139482A IE 53520 B1 IE53520 B1 IE 53520B1
Authority
IE
Ireland
Prior art keywords
formula
acid addition
compounds
addition salts
compound
Prior art date
Application number
IE1394/82A
Other languages
English (en)
Other versions
IE821394L (en
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR8111607A external-priority patent/FR2507602A1/fr
Priority claimed from FR8204331A external-priority patent/FR2523130A1/fr
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of IE821394L publication Critical patent/IE821394L/xx
Publication of IE53520B1 publication Critical patent/IE53520B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IE1394/82A 1981-06-12 1982-06-11 N-(4,5-dihydrothiazol-2-yl)-3-quinoline carboxamide derivatives IE53520B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8111607A FR2507602A1 (fr) 1981-06-12 1981-06-12 Nouveau derive dihydrothiazole de la quinoleine, ses sels, procede de preparation, application a titre de medicaments et compositions les renfermant
FR8204331A FR2523130A1 (fr) 1982-03-15 1982-03-15 Nouveaux derives de la n-dihydrothiazolyl-3-quinoleine carboxamide, leurs sels, procede de preparation, application a titre de medicaments et compositions les renfermant

Publications (2)

Publication Number Publication Date
IE821394L IE821394L (en) 1982-12-12
IE53520B1 true IE53520B1 (en) 1988-12-07

Family

ID=26222434

Family Applications (1)

Application Number Title Priority Date Filing Date
IE1394/82A IE53520B1 (en) 1981-06-12 1982-06-11 N-(4,5-dihydrothiazol-2-yl)-3-quinoline carboxamide derivatives

Country Status (16)

Country Link
US (1) US4450166A (ko)
EP (1) EP0067772B1 (ko)
KR (1) KR880000808B1 (ko)
AU (1) AU552029B2 (ko)
CA (1) CA1216795A (ko)
DE (1) DE3262536D1 (ko)
DK (1) DK150070C (ko)
ES (1) ES8304567A1 (ko)
FI (1) FI78087C (ko)
GR (1) GR77201B (ko)
HU (1) HU190796B (ko)
IE (1) IE53520B1 (ko)
IL (1) IL65943A (ko)
MA (1) MA19488A1 (ko)
NZ (1) NZ200931A (ko)
PT (1) PT75023B (ko)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2557570B1 (fr) * 1984-01-04 1986-04-18 Adir Nouveaux derives de la quinoleine, leur procede de preparation et les compositions pharmaceutiques les renfermant
FR2566405B1 (fr) * 1984-06-25 1986-09-26 Roussel Uclaf Nouveaux derives de l'acide 4-hydroxy 3-quinoleine carboxylique substitues en 2 par une fonction aminee, leur preparation, leur application comme medicaments, les compositions les renfermant et les intermediaires nouveaux obtenus
US4602014A (en) * 1984-07-09 1986-07-22 Ciba-Geigy Corporation Ring-fused pyrazolo[3,4-d]-pyridin-3-one derivatives as benzodiazepine receptor modulators
US4560692A (en) * 1984-07-18 1985-12-24 Hoffmann-La Roche Inc. 4-Piperidino-2-phenylquinolines
US4786644A (en) * 1987-11-27 1988-11-22 Hoechst-Roussel Pharmaceuticals Inc. 1-aryl-3-quinolinecarboxamide
BR9908321A (pt) 1998-02-26 2001-12-18 Neurogen Corp Composto
BR0010308A (pt) * 1999-05-06 2002-01-08 Neurogen Corp Composto, composição farmacêutica, uso de um composto, e, métodos para o tratamento de uma doença ou distúrbio associados com o agonismo patogênico, agonismo inverso ou antagonismo do receptor de gabaa, para localizar receptores de gabaa em uma amostra de tecido, para inibir a ligação de um composto de benzodiazepina a um receptor de gabaa e para alterar a atividade da transdução de sinal dos receptores de gabaa, e, composição farmacêutica embalada
US20100074949A1 (en) 2008-08-13 2010-03-25 William Rowe Pharmaceutical composition and administration thereof
US8354427B2 (en) * 2004-06-24 2013-01-15 Vertex Pharmaceutical Incorporated Modulators of ATP-binding cassette transporters
ES2656017T3 (es) 2004-06-24 2018-02-22 Vertex Pharmaceuticals Incorporated Moduladores de transportadores del casete de unión a ATP
WO2007075901A2 (en) * 2005-12-24 2007-07-05 Vertex Pharmaceuticals Incorporated Quinolin- 4 - one derivatives as modulators of abc transporters
DK3219705T3 (da) 2005-12-28 2020-04-14 Vertex Pharma Farmaceutiske sammensætninger af den amorfe form af n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinolin-3-carboxamid
EP3330255B1 (en) 2009-03-20 2020-12-09 Vertex Pharmaceuticals Incorporated Process for making modulators of cystic fibrosis transmembrane conductance regulator
US8802700B2 (en) 2010-12-10 2014-08-12 Vertex Pharmaceuticals Incorporated Modulators of ATP-Binding Cassette transporters
AU2013226076B2 (en) 2012-02-27 2017-11-16 Vertex Pharmaceuticals Incorporated Pharmaceutical composition and administration thereof
JP6746569B2 (ja) 2014-10-07 2020-08-26 バーテックス ファーマシューティカルズ インコーポレイテッドＶｅｒｔｅｘ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃｏｒｐｏｒａｔｅｄ 嚢胞性線維症膜貫通コンダクタンス制御因子のモジュレーターの共結晶

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1364605A (fr) * 1962-03-01 1964-06-26 Procédé de préparation d'amides des acides carboxyliques
FR2281761A1 (fr) * 1974-08-13 1976-03-12 Roussel Uclaf Nouveaux derives de l'acide 3-quinoleine carboxylique, leur procede de preparation et leur application comme medicament
FR2324304A2 (fr) * 1975-09-22 1977-04-15 Roussel Uclaf Nouveaux derives de l'acide 3-quinoleine carboxylique, leur procede de preparation et leur application comme medicament
FR2340735A1 (fr) * 1976-02-11 1977-09-09 Roussel Uclaf Nouveaux derives de l'acide 3-quinoleine carboxylique, leur procede de preparation et leur application comme medicament
FR2377400A2 (fr) * 1977-01-18 1978-08-11 Roussel Uclaf Nouveaux derives de l'acide 3-quinoleine carboxylique, leur procede de preparation et leur application comme medicament
FR2443467A1 (fr) * 1978-12-08 1980-07-04 Roussel Uclaf Nouveaux derives de l'acide 3-quinoleine carboxylique, leur procede de preparation et leur application comme medicament
FR2482596A1 (fr) * 1980-05-19 1981-11-20 Roussel Uclaf Nouveaux derives de l'acide 4-hydroxy 3-quinoleine carboxylique substitues en 2, leur procede de preparation et leur application comme medicament

Also Published As

Publication number Publication date
PT75023B (fr) 1985-05-17
MA19488A1 (fr) 1982-12-31
GR77201B (ko) 1984-09-11
IL65943A0 (en) 1982-09-30
KR880000808B1 (ko) 1988-05-11
AU8482782A (en) 1982-12-16
DK150070C (da) 1987-11-09
DK150070B (da) 1986-12-01
PT75023A (fr) 1982-07-01
ES512852A0 (es) 1983-03-01
NZ200931A (en) 1984-12-14
IE821394L (en) 1982-12-12
EP0067772B1 (fr) 1985-03-13
EP0067772A1 (fr) 1982-12-22
DE3262536D1 (en) 1985-04-18
ES8304567A1 (es) 1983-03-01
HU190796B (en) 1986-11-28
KR840000541A (ko) 1984-02-25
FI822067A0 (fi) 1982-06-10
US4450166A (en) 1984-05-22
FI78087B (fi) 1989-02-28
IL65943A (en) 1985-12-31
CA1216795A (fr) 1987-01-20
DK262782A (da) 1982-12-13
FI78087C (fi) 1989-06-12
AU552029B2 (en) 1986-05-22

Similar Documents

Publication Publication Date Title
IE53520B1 (en) N-(4,5-dihydrothiazol-2-yl)-3-quinoline carboxamide derivatives
US4307095A (en) Method of treating schizophrenia with cycloalkltriazoles
EP0343893B1 (en) Aromatic and heterocyclic carboxamide derivatives as antineoplastic agents
CS251795B2 (en) Method of 5h-2,3-benzodiazepine's derivatives preparation
JPH0363276A (ja) 新規な５，１１―ジヒドロ―６Ｈ―ジピリド〔３，２―ｂ：２′，３′―ｅ〕〔１，４〕ジアゼピン―６―オンおよび該化合物を含有するＡＩＤＳの予防および治療用医薬組成物
US3752823A (en) N alkyl tetrahydrocarbazoles
FI73999C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara piperazinyl-imidazo/4,5-b/- och -/4,5-c/ pyridiner samt mellanprodukt anvaendbar vid det.
EP0046572B1 (en) 6-quinazolinesulfonyl derivatives and process for preparation thereof
EP0138198B1 (en) Isoindole diuretic derivatives
SK116494A3 (en) Bis-arylcarbinol derivatives, pharmaceutical preparations and their use
GB2180535A (en) Gamma-carbolines
SU927111A3 (ru) Способ получени оксимэфиров или их солей
RU2309950C2 (ru) Производные пиридинамидов и лекарственное средство на их основе
JPH0368574A (ja) 薬学的に活性なアミノイミダゾピリジン
US4325952A (en) Method of treating abstinence syndrome with cycloaklyltriazoles
JPH01193264A (ja) 精神分裂病の治療に有効な１−（（５−（（４−置換−１−ピペラジニル）メチル）−ピロール−２−イル又はフラン−２−イル）メチル−２−ピペリジノン類
GB2130207A (en) 2-piperazinyl-and homopiperazinyl quinazoline derivatives their production and pharmaceutical compositions containing them
HU196998B (en) Process for producing basically substituted pyridine derivatives and pharmaceuticals comprising same
JPS60184081A (ja) ７，８‐ジヒドロイミダゾ［１，５‐ａ］ピラジン‐８‐オン類
US4391811A (en) 2-Amino-6-(pyridinyl)-3H-imidazo[4,5-b]pyridines and their cardiotonic use
CS195731B2 (en) Process for preparing n-/5-tetrazolyl/-1-oxo-1h-6-alkoxypyrimido/1,2-a/quinolin-2-carboxamides
JPH0530828B2 (ko)
FI81801B (fi) Foerfarande foer framstaellning av terapeutiskt aktiva 5-klor-s-triazolo/4,3-a/pyridin-7-karboxylsyror.
PL100988B1 (pl) Sposob wytwarzania nowych pochodnych naftyrydynylo-piroliny
CA1073454A (en) Imidazolobenzodiazepines, processes for their preparation and compositions incorporating them